98%
921
2 minutes
20
The optrA gene encodes an ABC-F protein which confers cross-resistance to oxazolidinones and phenicols. Insertion sequence ISVlu1, a novel ISL3-family member, was recently reported to be involved in the transmission of optrA in Vagococcus lutrae. However, the role of ISVlu1 in mobilizing resistance genes has not yet fully explored. In this study, two complete and three truncated copies of ISVlu1 were found on plasmid pBN62-optrA from Lactococcus garvieae. Analysis of the genetic context showed that both optrA and the phenicols resistance gene fexA were flanked by the complete or truncated ISVlu1 copies. Moreover, three different-sized ISVlu1-based translocatable units (TUs) carrying optrA and/or fexA, were detected from pBN62-optrA. Sequence analysis revealed that the TU-optrA was generated by homologous recombination while TU-fexA and TU-optrA+fexA were the products of illegitimate recombinations. Importantly, conjugation assays confirmed that pBN62-optrA was able to successfully transfer into the recipient Enterococcus faecalis JH2-2. To our knowledge, this is the first report about an optrA-carrying plasmid in L. garvieae which could horizontally transfer into other species. More importantly, the ISVlu1-flanked genetic structures containing optrA and/or fexA were also observed in bacteria of different species, which underlines that ISVlu1 is highly active and plays a vital role in the transfer of some important resistance genes, such as optrA and fexA.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.vetmic.2024.110048 | DOI Listing |
Sci Rep
August 2025
Department of Food Hygiene and Control, Faculty of Veterinary Medicine, Aswan University, Aswân, 81528, Egypt.
Staphylococcus aureus is the causative agent of zoonotic diseases that are of increasing epidemiological importance and have significant implications for public health. One hundred fifty ready-to-eat meat product samples were collected from local shops in Qena City, Egypt, to investigate the bacteriological profile of S. aureus and evaluate the antimicrobial effects of marine algal extracts against identified S.
View Article and Find Full Text PDFJ Hosp Infect
August 2025
Department of Internal medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Background: Antimicrobial resistance is an emergent threat, with Carbapenemase-Producing Enterobacterales (CPE) and Vancomycin-Resistant Enterococcus (VRE) posing substantial challenges. We investigated CPE/VRE acquisition and spread in hospitalized patients by analysing resistance genes and microbiomes using whole genome sequencing (WGS) and exploring epidemiological and clinical risk factors.
Methods: This retrospective study included patients from the infectious disease department of a tertiary hospital.
BMC Infect Dis
August 2025
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China.
Background: Immunocompromised cancer patients represent a susceptible population for enterococcal infections. While linezolid remains the primary therapeutic option for vancomycin-resistant Enterococcus (VRE) infections, the emergence of linezolid-resistant Enterococcus (LRE) worldwide has not only exacerbated public health risks but also posed significant challenges to clinical treatment. This study aimed to analyze the prevalence of LRE isolates among cancer patients in China and to investigate the mechanisms of linezolid resistance.
View Article and Find Full Text PDFAccess Microbiol
April 2025
Laboratory of Food Microbiology and Food Safety, Department of Health and Environmental Sciences, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, 069-8501, Hokkaido, Japan.
Mobile linezolid-resistance genes (, and ) that confer resistance to linezolid and florfenicol have been detected globally in various sources. Linezolid is a last-resort antimicrobial used in human clinical settings, and florfenicol is commonly used in veterinary clinical settings. The present study sought to evaluate the potential of florfenicol in veterinary use to select for linezolid-resistant bacteria.
View Article and Find Full Text PDFJ Antimicrob Chemother
September 2025
Institute of Animal Husbandry and Veterinary Medicine, Fujian Academy of Agricultural Sciences, Fuzhou, China.